Baseline bone mineral density in patients for whom both baseline and end-of-treatment scans were available (n=16)
| Budesonide | Placebo | |
| Subjects n | 82 | 79 |
| Femoral neck g·cm2 | 0.89±0.15 (0.59–1.26) | 0.85±0.16 (0.57–1.33) |
| Femoral trochanter g·cm2 | 0.79±0.16 (0.38–1.21) | 0.77±0.17 (0.45–1.22) |
| Femoral Ward’s triangle g·cm2 | 0.69±0.19 (0.35–1.14) | 0.66±0.20 (0.31–1.27) |
| L2–L4 g·cm2 | 1.09±0.17 (0.58–1.59) | 1.06±0.19 (0.67–1.60) |
Data are presented as mean ± sd (range)